Back to results
CompletedPhase 4

Antiischemic Effects of Empagliflozin in Diabetic Patients With Refractory Angina

NCT04143321

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Cardiac rehabilitation research center

Isfahan, Iran

View on ClinicalTrials.gov
Antiischemic Effects of Empagliflozin in Diabetic Patients With Refractory Angina — TrialFind